Company / Working Capital per Share
Cytek Biosciences, Inc. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$2.44
FY2025
5-year range
$2.44 / $12.76
FY2021-FY2025
Trend
-4.0%
vs FY2024
Sector context
#111 of 158
Health Care
What the data says
At $2.44, Cytek Biosciences, Inc.'s working capital per share ranks #111 of 158 in the Health Care sector. Working Capital per Share has declined for 4 consecutive years, from $12.76 in FY2021 to $2.44 in FY2025.
Based on SEC 10-K filings.
2.44 in FY2025 with a 5-year CAGR of -15.2%.
Declined from $2.57 to $2.44 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -6.9%
- 5-Year CAGR
- -15.2%
- 10-Year CAGR
- -
Sector benchmark
#111 of 158 in Health CareTop 70% of 158This company $2.44 Sector average $24.43
▼
-90.0% below sector average
Key checks
Key Insights
- Cytek Biosciences, Inc.'s working capital per share has declined for 4 consecutive years.
- In FY2025, working capital per share decreased 4.0% year-over-year.
- Ranks #111 out of 158 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.44 | -4.0% |
| FY2024 | $2.54 | -1.0% |
| FY2023 | $2.57 | -15.1% |
| FY2022 | $3.03 | -76.3% |
| FY2021 | $12.76 | +128.4% |
| FY2020 | $5.59 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026